Page last updated: 2024-10-19

melatonin and Uveal Neoplasms

melatonin has been researched along with Uveal Neoplasms in 3 studies

Uveal Neoplasms: Tumors or cancer of the UVEA.

Research Excerpts

ExcerptRelevanceReference
" One hundred patients recently diagnosed with non-metastatic uveal melanoma will be randomized to either treatment with adjuvant melatonin 20 mg (4 tablets of 5 mg) at 10 pm for 5 years, or to standard follow-up (control group)."9.69Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study. ( Hagström, A; Kal Omar, R; Stålhammar, G, 2023)
"The effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells were studied."7.70Effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells. ( Hu, DN; McCormick, SA; Roberts, JE, 1998)
"Melatonin may also enhance the efficacy of cancer treatments such as immuno- and chemotherapy."6.82The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature. ( Hagström, A; Kal Omar, R; Stålhammar, G; Williams, PA, 2022)
" One hundred patients recently diagnosed with non-metastatic uveal melanoma will be randomized to either treatment with adjuvant melatonin 20 mg (4 tablets of 5 mg) at 10 pm for 5 years, or to standard follow-up (control group)."5.69Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study. ( Hagström, A; Kal Omar, R; Stålhammar, G, 2023)
"The effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells were studied."3.70Effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells. ( Hu, DN; McCormick, SA; Roberts, JE, 1998)
"Melatonin may also enhance the efficacy of cancer treatments such as immuno- and chemotherapy."2.82The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature. ( Hagström, A; Kal Omar, R; Stålhammar, G; Williams, PA, 2022)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Hagström, A2
Kal Omar, R2
Williams, PA1
Stålhammar, G2
Hu, DN1
McCormick, SA1
Roberts, JE1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Adjuvant Melatonin for Uveal Melanoma: A Randomized Open Phase III Study[NCT05502900]Phase 3100 participants (Anticipated)Interventional2022-10-02Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for melatonin and Uveal Neoplasms

ArticleYear
The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature.
    BMC cancer, 2022, Apr-13, Volume: 22, Issue:1

    Topics: Humans; Melanoma; Melatonin; Uveal Neoplasms

2022

Trials

1 trial available for melatonin and Uveal Neoplasms

ArticleYear
Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study.
    Trials, 2023, Mar-26, Volume: 24, Issue:1

    Topics: Adult; Clinical Trials, Phase III as Topic; Humans; Melanoma; Melatonin; Randomized Controlled Trial

2023

Other Studies

1 other study available for melatonin and Uveal Neoplasms

ArticleYear
Effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells.
    Melanoma research, 1998, Volume: 8, Issue:3

    Topics: Cell Division; Dose-Response Relationship, Drug; Humans; Kynurenine; Melanoma; Melatonin; Serotonin;

1998